High Quality Food Supplements & Medical Devices since 1987

ERBOZETA S.p.A was established in 1987 in the Republic of San Marino as a commercial company with the passion towards natural health products, especially food supplements.

It appeared necessary to internalize production to be able to guarantee the best quality: the only way was to manage internally the production starting with solid forms such as capsules and tablets, and liquid forms such as syrups and drops.

In the beginning of the 2000’s, ERBOZETA started growing its reputation and expanded in the whole territory of Italy, adding new products to its portfolio and building a team of Medical representatives visiting doctors all over the country.

The necessity of increasing its production capacity was fundamental to maintain the growth of the company therefore investments were made in order to improve the machinery.

The portfolio was significantly enlarged and ERBOZETA started selling first products abroad. In 2008, the subsidiary company PHARMALUCE S.r.L was founded.

2009 marked a new beginning for ERBOZETA a major investment was made to build a new state of-the-art production facility of 2500 m2 in compliance with the highest pharmaceutical standards. The site was designed with Clean Rooms and Climatic Rooms, monitoring constantly TEMPERATURE, HUMIDITY and PRESSURE, with an area exclusively dedicated to the manufacturing of probiotics, under specific conditions. Not only the manufacturing itself was re-designed, but also Erbozeta decided to acquire new innovative machines such as fluid bed granulator and Long Life single-dose bottles.

The group started expanding its presence in foreign countries. In 2013, the subsidiary company LOGUS PHARMA S.r.l. was founded.

ERBOZETA has observed a remarkable expansion into foreign markets, with a presence in more than 40 countries in the world, increasing accordingly its production capacity and warehouse space to 2500 m2, adding also new pharmaceutical forms.

In 2014, the European branch in Vienna was established, Erbozeta Austria GmbH.
ERBOZETA started with the first productions of Medical Devices class I such as nasal sprays, and throat sprays.

Due to a strong expansion in Asian markets, the Asian branch was established in Hong Kong, Erbozeta Asia LTD

After investing significantly into machinery innovation and quality of its manufacturing site, the necessity was to add other official recognitions such as certifications.

Not only the company was approved by several foreign Ministries of Health, such as Libya, Iraq, USA, Kazakhstan but also with certifications recognized at an international level. Indeed in 2017, ERBOZETA obtained the ISO 13485 certification, followed by LOGUS PHARMA in 2018 and PHARMALUCE
in 2019.

In 2019, due to an expansion in Central America, ERBOZETA decided to add a new commercial branch, Erbozeta Iberica LDA.

In addition, ERBOZETA made major investments in the machinary and manufacturing site: new blistering machine, new mixing tanks to increase productivity, with ALU/ALU blisters, high performing solid stick machine.

Our medical devices have been certified by renowned accredited certifying bodies.

In the last years, Erbozeta has been more and more paying attention to environment protection and promoting a sustainable lifestyle thanks to some important actions:
- transition to green energy by installing solar panels on its roof, thus allowing to produce its own solar energy for the manufacturing site, warehouses and offices.
- sustain a plastic-free life in working hours, with the introduction of water purifying systems and water bottles in our offices.

ERBOZETA GROUP is an example of INNOVATION, QUALITY and SAFETY. It’s now present in more than 70 countries in the world with a worldwide reputation. Our product range covers more than 20 specialties, with over 150 products, including Food Supplements, Medical Devices, Food for Special Medical Purposes and Cosmetics.

With 170 employees, and 220 national medical representatives and hundreds of international business partners, ERBOZETA GROUP is planning on maintaining its growth by giving innovative response to the worldwide market needs.